Everfine(SZ:300306)2020-08-27 16:00Financial Performance - The company's operating revenue for the reporting period was ¥165,436,785.89, a decrease of 12.81% compared to ¥189,742,471.50 in the same period last year [27]. - The net profit attributable to shareholders of the listed company was ¥31,817,903.94, down 56.75% from ¥73,571,992.38 in the previous year [27]. - The net profit after deducting non-recurring gains and losses was ¥37,173,555.61, an increase of 25.52% compared to ¥29,614,619.87 in the same period last year [27]. - The net cash flow from operating activities was -¥1,050,121.17, a decline of 101.94% from ¥54,221,201.34 in the previous year [27]. - Basic earnings per share decreased to ¥0.12 from ¥0.26, a drop of 53.85% [27]. - The company's total assets at the end of the reporting period were ¥1,577,292,306.63, a decrease of 0.97% from ¥1,592,771,923.18 at the end of the previous year [27]. - The net assets attributable to shareholders of the listed company increased by 3.36% to ¥1,449,761,492.43 from ¥1,402,570,140.78 at the end of the previous year [27]. - The weighted average return on net assets was 2.24%, down 2.81% from 5.05% in the previous year [27]. - The company achieved operating revenue of 165.44 million yuan, a decrease of 12.81% compared to the same period last year [51]. - Operating profit was 21.82 million yuan, down 73.09% year-on-year, while total profit decreased by 73.10% to 21.86 million yuan [38]. - The decline in profit was primarily due to the fair value changes related to performance compensation for Weir Technology, with a 4.14% decrease in operating profit after excluding this impact [38]. Investment and Financial Management - The company has sold part of its shares in Jin Dun Co. due to significant stock price declines, indicating a proactive approach to managing investment risks [6]. - The company will not distribute cash dividends or issue bonus shares, focusing instead on reinvestment for growth [14]. - The company reported a total of CNY 63,218.88 million in raised funds, with CNY 1,209.41 million utilized during the reporting period [73]. - Cumulative investment of raised funds reached CNY 71,281.27 million, with a total of CNY 8,062.39 million in net interest received [76]. - The company has permanently supplemented working capital with surplus funds from three projects, totaling RMB 24.22 million [81]. - The cumulative use of surplus funds for the establishment of the wholly-owned subsidiary in the US amounted to RMB 30.32 million, with surplus funds of RMB 22.32 million remaining [81]. Legal and Compliance Issues - The company is involved in ongoing litigation regarding the control of Huijing Technology, which has resulted in uncertainty regarding its financial reporting and operational control [12]. - The company has initiated litigation against 10 defendants regarding a stock transfer dispute, with a total asset value of CNY 70,345,300 subject to preservation measures [104]. - Compensation obligations from 18 parties amount to CNY 19 million in cash and 21,332,667 shares, with cash compensation completed and 13,099,099 shares repurchased and canceled [105]. - The company has filed a civil lawsuit for the remaining 8,233,568 shares and unreturned cash dividends of CNY 5,717,154.76, with the court supporting some of the company's claims [105]. - The company is appealing a first-instance judgment regarding the compensation obligations, with the case accepted by the Zhejiang High Court [106]. - The company has not engaged in any entrusted financial management, derivative investments, or entrusted loans during the reporting period [84][85][86]. Operational Challenges - The company is experiencing challenges with its subsidiaries, including a significant decline in performance from Yi Gene and poor conditions in Mingzhan Network and Mingzhi Education [6]. - The impact of COVID-19 resulted in delayed resumption of operations and reduced customer demand, particularly affecting Weir Technology's driver training and examination business [37]. - The company faces risks related to policy changes affecting its biometric recognition business, particularly in transportation and finance sectors [8]. - Internal management risks have increased due to the growth in asset scale and the number of subsidiaries, necessitating improvements in governance and management practices [100]. Research and Development - R&D investment reached 32.33 million yuan, accounting for 19.54% of the company's operating revenue [48]. - The company holds over 180 patents in the field of optical detection, including more than 60 invention patents [40]. - The company plans to strengthen R&D of high-end detection equipment and participate in the formulation of international standards to lead core detection technology development [39]. Market Position and Strategy - The company's smart detection and identification business maintained stable development, with a relatively high gross margin, although increased competition in the biometric recognition sector poses risks to future performance [5]. - The company plans to actively utilize existing technology and industry advantages to drive innovation and enhance market competitiveness, particularly in the smart detection niche market [5]. - The company is positioned as a leading enterprise in the domestic market for detection information equipment, particularly in optical detection and calibration services [40]. - The company continues to focus on customer needs, providing efficient detection systems and application solutions [51]. Shareholder Information - Major shareholder Pan Jiangen holds 29.18% of the shares, totaling 80,067,960 shares [158]. - The second largest shareholder, Hangzhou Yuanfang Changyi Investment Co., Ltd., holds 18.50% of the shares, totaling 50,767,560 shares [158]. - The total number of ordinary shareholders at the end of the reporting period was 15,276 [158]. - The company reported a decrease in restricted shares from 130,128,307 (47.43%) to 124,019,281 (45.20%) due to the release of 6,109,026 shares [150].